BioNano Genomics stock forecast
BioNano Genomics (2Y3) Stock Forecast & Price Target
2Y3 Analyst Ratings
2Y3 Stock 12 Month Forecast
Average Price Target
€3.58▼(-18.40% Downside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Jason McCarthy | Maxim Group | €3.58 | buy | -18.40%Downside | Reiterated | 09/10/26 | ||
| Yi Chen | H.C. Wainwright | €6.27→€5.37 | buy | 22.40%Upside | Reiterated | 04/13/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Jason McCarthyMaxim Group | BuyReiterated€3.58 | 09/10/26 | -18.40%Downside | ||
| Yi ChenH.C. Wainwright | BuyReiterated€6.27→€5.37 | 04/13/26 | 22.40%Upside |
Best Analysts Covering BioNano Genomics
Copying Jason McCarthy's trades and holding each position for 3 Months would result in 12.50% of your transactions generating a profit, with an average return of -11.81% per trade.
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -21.05% per trade.
Copying Jason McCarthy's trades and holding each position for 2 Years would result in 12.50% of your transactions generating a profit, with an average return of -21.38% per trade.
2Y3 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 1 | 2 | 2 | 1 |
In the current month, 2Y3 has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2Y3 average Analyst price target in the past 3 months is 3.58.
2Y3 Financial Forecast
2Y3 Earnings Forecast
Next quarter’s earnings estimate for 2Y3 is -EUR 0.35 with a range of -EUR 0.35 to -EUR 0.35. The previous quarter’s EPS was -EUR 0.41. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
2Y3 Sales Forecast
Next quarter’s sales forecast for 2Y3 is EUR 8.32M with a range of EUR 8.32M to EUR 8.32M. The previous quarter’s sales results were EUR 7.51M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

